BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2005
View Archived Issues
Rats receiving CRF1 antagonist show reduction in submissive behavior
Read More
Ligand updates status of inhouse and partnered programs
Read More
Efficacy of LJ-529 in ER-negative breast cancer models
Read More
SPC-2968, an HIF-1 inhibitor, in preparation for initial clinical studies in 2006
Read More
Preclinical efficacy reported for GI-5005, a therapeutic vaccine for chronic hepatitis C infection
Read More
Enzon Pharmaceuticals and Micromet end research collaboration
Read More
European Commission approval for Teva's acquisition of Ivax
Read More
PharmaGap and OHSU Cancer Institute to collaborate on PKC inhibitors
Read More
GSK and Institut Pasteur collaborate to develop AIDS vaccine
Read More
American Pharmaceutical Partners to merge with American Bioscience
Read More
BioCryst submits IND for injectable formulations of peramivir
Read More
Enrollment completed in phase III study of Entereg in postoperative ileus
Read More
Phase III trials begin for PF-3512676 for NSCLC
Read More
Leo Pharma and Foamix to develop medicated foams for psoriasis
Read More
Agile completes phase II study for low estrogen contraceptive patch
Read More
Quadramet studied in combination with bortezomib for multiple myeloma
Read More
Neuren signs memorandum of understanding for Glypromate phase III trial
Read More
GW-610: new anticancer agent with potent and selective profile
Read More
New class of selective, orally active MEK1/2 inhibitors for cancer therapy
Read More
Feasibility of Syk kinase inhibition with R-406 demonstrated
Read More
Studies suggest benefit of IL-1 TRAP in atherosclerosis, CIAS1-associated syndromes
Read More
Ambrisentan beneficial in patients with connective tissue diseases and PAH
Read More
Obese, dyslipidemic subjects lose weight on rimonabant
Read More
Solvay suspends regulatory activities for cilansetron in U.S.
Read More
New antihepatitis C agents described in recent GSK patent
Read More
Novel agents for diabetes and related complications reported in recent patent literature
Read More